Country: Cyprus
Language: Greek
Source: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας
CEFIXIME
BIAL-PORTELA & CA, SA (0000003750) A AV. DA SIDERURGIA NACIONAL, S. MAMEDE DO CORONADO, 4745-457
J01DD08
CEFIXIME
100MG/5ML
POWDER FOR ORAL SUSPENSION
CEFIXIME (0079350371) 100MG
ORAL USE
Εθνική Διαδικασία
CEFIXIME
Νομικό καθεστώς: Με Ιατρική Συνταγή; PACK WITH 1 BOTTLE X 60ML (200036402) 60 MILLILITRE - Εγκεκριμένο - Με Ιατρική Συνταγή
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF MEDICINAL PRODUCT TRICEF, 100 mg/5ml, powder for oral suspension. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 5 mL of oral suspension contains 100 mg cefixime. Excipient with known effect: Sucrose – 505.022 mg/mL For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Powder for oral suspension. White to pale cream powder with strawberry odor. 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS Tricef is indicated for the treatment of the following infections caused by susceptible agents (see section 4.4 and 5.1): - Acute otitis media - Upper respiratory tract infections (pharyngitis, tonsillitis, sinusitis) - Lower respiratory tract infections ( acute exacerbations of chronic bronchitis, community acquired pneumonia); - Urinary tract infections (acute cystitis, uncomplicated acute pyelonephritis); - Uncomplicated gonococcal cervicitis and urethritis. Consideration should be given to national and/or local guidelines on the appropriate use of antibiotics. 4.2. POSOLOGY AND METHOD OF ADMINISTRATION The usual recommended posology is 8 mg/kg, single dose. In terms of the pharmaceutical form, the dosage is generally as follows: - _Children aged 2-4 years_: 1 measuring spoon every 24h; ½ measuring spoon every 12 hours. - _Children aged 5-8 years_: 2 measuring spoons every 24h; 1 measuring spoon every 12 hours. - _Children aged 9-12 years_: 3 measuring spoons every 24h; 1½ measuring spoon every 12 hours. - _Patients with renal impairment_: The medicine may be administered to patients with impaired renal function. 1 Doses indicated above may be given in patients with creatinine clearance of 20 mL/min or above. . In patients whose creatinine clearance is less than 20 mL/min, it is recommended not to exceed a daily dose of 200 mg. This dose should also not be exceeded in patients undergoing chronic peritoneal dialysis or hemodialysis, since cefixime is slowly removed from circulation by dialysis. In patients with impaired liver function, there is an i Read the complete document